Balyasny Asset Management LLC Elevation Oncology, Inc. Transaction History
Balyasny Asset Management LLC
- $54.8 Billion
- Q1 2024
A detailed history of Balyasny Asset Management LLC transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 3,055,479 shares of ELEV stock, worth $8.25 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,055,479Holding current value
$8.25 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ELEV
# of Institutions
65Shares Held
44MCall Options Held
700Put Options Held
0-
Farallon Capital Management LLC San Francisco, CA3.89MShares$10.5 Million0.09% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.37MShares$9.09 Million0.04% of portfolio
-
Tang Capital Management LLC San Diego, CA3.06MShares$8.26 Million1.91% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$7.65 Million4.98% of portfolio
-
Ven Bio Partners LLC San Francisco, CA2.7MShares$7.28 Million5.41% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $62.9M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...